Findings of Research Misconduct

Notice Number: NOT-OD-12-114

Key Dates
Release Date: June 8, 2012

Issued by
Department of Health and Human Services (DHHS)


SUMMARY: Notice is hereby given that the Office of Research Integrity (ORI) has taken final action in the following case:

Jian Ma, Ph.D., Brigham and Women's Hospital and Harvard Medical School: Based on evidence and findings of an inquiry conducted jointly by Brigham and Women's Hospital (BWH) and Harvard Medical School (HMS) and additional evidence gathered by the Office of Research Integrity (ORI) during its oversight review, ORI found that Dr. Jian Ma, former Research Fellow, BWU, engaged in research misconduct in research supported by National Cancer Institute (NCI), National Institutes of Health (NIH), grant 5 P01 CA120964.

ORI found that the Respondent knowingly and intentionally fabricated and falsified data in portions of figures in an unpublished manuscript titled ``TSC1 loss synergizes with KRAS activation in lung cancer development and confers rapamycin sensitivity' by M.-C. Liang, J. Ma, L. Chen, P. Kozlowski, W. Qin, D. Li, T. Shimamura, M.L. Sos, R. Thomas, D. Neil Hayes, M. Meyerson, D.J. Kwiatkowski, and K.-K. Wong, submitted to the Journal of Clinical Investigation (JCI) on August 5, 2008, and in revised form on October 21, 2008 (hereafter referred to as the ``JCI manuscript').

Specifically, Respondent committed research misconduct by knowingly and intentionally:

    The JCI manuscript was accepted by JCI on December 8, 2008, but it was withdrawn by one of the authors on January 6, 2009.
    ORI found that Respondent's knowing and intentional falsification and fabrication of data constitutes research misconduct within the meaning of 42 CFR 93.103.

    The following administrative actions have been implemented for a period of three (3) years, beginning on May 12, 2012:

    (1) Any institution that submits an application for U.S. Public Health Service (PHS) support for a research project on which Respondent's participation is proposed or that uses him in any capacity on PHS-supported research must concurrently submit a plan for supervision of his duties to the funding agency for approval; the supervisory plan must be designed to ensure the scientific integrity of his research contribution; Respondent must ensure that a copy of the supervisory plan is also submitted to ORI by the institution; Respondent will not participate in any PHS-supported research until such a supervisory plan is submitted to ORI;

    (2) Respondent will ensure that any institution employing him submits, in conjunction with application for PHS funds or any report, manuscript, or abstract of PHS-funded research in which he is involved, a certification that the data provided by him are accurately reported in the application or report; Respondent must ensure that the institution send the certification to ORI; this certification shall be submitted no later than one month before funding and concurrently with any report, manuscript, or abstract; and

    (3) Respondent is prohibited from serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant.


    Division of Investigative Oversight
    Office of Research Integrity
    1101 Wootton Parkway, Suite 750
    Rockville, MD 20852
    (240) 453-8800

    Weekly TOC for this Announcement
    NIH Funding Opportunities and Notices

    Office of Extramural Research (OER) - Home Page Office of Extramural
    Research (OER)
      National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
    9000 Rockville Pike
    Bethesda, Maryland 20892
      Department of Health and Human Services (HHS) - Home Page Department of Health
    and Human Services (HHS) - Government Made Easy
    NIH . . . Turning Discovery Into Health

    Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.